Pub Date : 2021-01-10DOI: 10.15789/1563-0625-aor-2047
S. Popov, I. Shmelkov, S. Khaidukov
Morbidity and mortality rates in invasive mycoses determine the need to improve methods for their timely diagnosis by assessment the patients’ immune status. Evaluation of individual immune status allows the clinician to predict the development and course of fungal infections. At the same time, identification of opportunistic mycosis in immunocompetent patients should require a search for some hidden immune deficiency. Determining the cause of such immune defects can help develop an effective strategy for both etiotropic and immune therapy of patients with invasive mycoses. Currently, the functions of regulatory T lymphocytes that support immunological tolerance in fungal infections remain to be incompletely studied. In this review, we present experimental works which suggest that the regulatory T lymphocytes are able to suppress immune responses to fungi by stimulating the immunosuppressive environment. It was shown that regulatory T lymphocytes use Toll-like receptor 2 to achieve immunosuppression in Candida infections. The balance between the number and function of regulatory T lymphocytes is essential for elimination of fungal pathogens and protection against post-infectious immunopathological conditions. It was found that the regulatory T lymphocytes provide protection at an early stage of Candida infection, since, due to IL-2 suppression, they enhance Th17 differentiation and clearance of fungi. Moreover, at the later stages of infection, the regulatory T lymphocytes have an inhibitory effect. The balance between Th17 and regulatory T lymphocytes in mucosal lining is considered the main factor for distinguishing between commensal carriage and Candida albicans infection. The study is presented which indicate that disseminated candidiasis associated with expansion of regulatory T lymphocytes stimulates a Th17-cell response that controls the course of the disease. The mechanisms that control regulatory T lymphocytes homeostasis are essential for providing effective protection against pathogens, as well as for controlling the immunopathological conditions associated with Candida infection. The review presents data that have established the role of TGF-β1 in increasing the viability of regulatory T lymphocytes, which is correlated with the pronounced immunomodulating role of these cells at the later phase of Candida infections of the mucous membrane. It has been also demonstrated that the pulmonary regulatory Tlymphocytes are induced during cryptococcal infection, which predominantly suppresses Th2 cells, thereby supporting its course. Expansion of the regulatory T lymphocytes upon administration of IL-2/antiIL-2 complex during cryptococcal infection led to a decrease in IgE production and a decrease in allergic airway inflammation. It should be noted that refinement of prognostic value of the regulatory T lymphocytes in human fungal infections may substantiate the basic principles of targeted immunotherapy.
{"title":"Analysis of regulatory T lymphocytes in fungal infections","authors":"S. Popov, I. Shmelkov, S. Khaidukov","doi":"10.15789/1563-0625-aor-2047","DOIUrl":"https://doi.org/10.15789/1563-0625-aor-2047","url":null,"abstract":"Morbidity and mortality rates in invasive mycoses determine the need to improve methods for their timely diagnosis by assessment the patients’ immune status. Evaluation of individual immune status allows the clinician to predict the development and course of fungal infections. At the same time, identification of opportunistic mycosis in immunocompetent patients should require a search for some hidden immune deficiency. Determining the cause of such immune defects can help develop an effective strategy for both etiotropic and immune therapy of patients with invasive mycoses. Currently, the functions of regulatory T lymphocytes that support immunological tolerance in fungal infections remain to be incompletely studied. In this review, we present experimental works which suggest that the regulatory T lymphocytes are able to suppress immune responses to fungi by stimulating the immunosuppressive environment. It was shown that regulatory T lymphocytes use Toll-like receptor 2 to achieve immunosuppression in Candida infections. The balance between the number and function of regulatory T lymphocytes is essential for elimination of fungal pathogens and protection against post-infectious immunopathological conditions. It was found that the regulatory T lymphocytes provide protection at an early stage of Candida infection, since, due to IL-2 suppression, they enhance Th17 differentiation and clearance of fungi. Moreover, at the later stages of infection, the regulatory T lymphocytes have an inhibitory effect. The balance between Th17 and regulatory T lymphocytes in mucosal lining is considered the main factor for distinguishing between commensal carriage and Candida albicans infection. The study is presented which indicate that disseminated candidiasis associated with expansion of regulatory T lymphocytes stimulates a Th17-cell response that controls the course of the disease. The mechanisms that control regulatory T lymphocytes homeostasis are essential for providing effective protection against pathogens, as well as for controlling the immunopathological conditions associated with Candida infection. The review presents data that have established the role of TGF-β1 in increasing the viability of regulatory T lymphocytes, which is correlated with the pronounced immunomodulating role of these cells at the later phase of Candida infections of the mucous membrane. It has been also demonstrated that the pulmonary regulatory Tlymphocytes are induced during cryptococcal infection, which predominantly suppresses Th2 cells, thereby supporting its course. Expansion of the regulatory T lymphocytes upon administration of IL-2/antiIL-2 complex during cryptococcal infection led to a decrease in IgE production and a decrease in allergic airway inflammation. It should be noted that refinement of prognostic value of the regulatory T lymphocytes in human fungal infections may substantiate the basic principles of targeted immunotherapy.","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67108299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-07DOI: 10.1201/9780824745097-12
{"title":"The Humoral Immune Response and Its Induction by Active Immunization","authors":"","doi":"10.1201/9780824745097-12","DOIUrl":"https://doi.org/10.1201/9780824745097-12","url":null,"abstract":"","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42514998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-07DOI: 10.1201/9780824745097-14
BACTERIAL INFECTIONS AND IMMUNITY Efficacy against Footrot of a Bacteroides nodosus 265 (Serogroup H) Pilus Vaccine Expressed in Pseudomonas aeruginosa. Thomas C. Elleman and David J. Stewart............................................................. 595-600 Susceptibility of HRS/J Mice to Listeriosis: Dynamics of Infection. Wendy A. Archinal and Martin S. Wilder .......... .............................. 607-612 Susceptibility of HRS/J Mice to Listeriosis: Macrophage Activity. Wendy A. Archinal and Martin S. Wilder .......... .............................. 613-618 Characterization of the Susceptibility of Pseudomonas aeruginosa to ComplementMediated Killing: Role of Antibodies to the Rough Lipopolysaccharide on Serum-Sensitive Strains. Neal L. Schiller.............................. 632-639 Chemical Cross-Linking of Chlamydia trachomatis. Svend Birkelund, Anker G. Lundemose, and Gunna Christiansen .................................. 654-659 Serial Isolates of Pseudomonas aeruginosa from a Cystic Fibrosis Patient Have Identical Pilin Sequences. Brittan L. Pasloske, A. Mark Joffe, Qiming Sun, Kathy Volpel, William Paranchych, Fereshteh Eftekhar, and David P. Speert .............................................................. 665-672 Interaction of Macrophage Cationic Proteins with the Outer Membrane of Pseudomonas aeruginosa. Janet G. Sawyer, Nancy L. Martin, and R. E. W. Hancock............................................................ 693-698 Agglutinating Monoclonal Antibodies That Specifically Recognize Lipooligosaccharide A of Bordetella pertussis. Zhong Ming Li, James L. Cowell, Michael J. Brennan, Drusilla L. Bums, and Charles R. Manclark ..... .... 699-702 Serological Response to the Outer Membrane Lipoprotein in Animal Brucellosis. Mania J. G6mez-Miguel, Ignacio Moriy6n, B. Alonso-Urmeneta, J. I. Riezu-Boj, and R. Diaz............................................... 716-718
{"title":"Infection and Immunity","authors":"","doi":"10.1201/9780824745097-14","DOIUrl":"https://doi.org/10.1201/9780824745097-14","url":null,"abstract":"BACTERIAL INFECTIONS AND IMMUNITY Efficacy against Footrot of a Bacteroides nodosus 265 (Serogroup H) Pilus Vaccine Expressed in Pseudomonas aeruginosa. Thomas C. Elleman and David J. Stewart............................................................. 595-600 Susceptibility of HRS/J Mice to Listeriosis: Dynamics of Infection. Wendy A. Archinal and Martin S. Wilder .......... .............................. 607-612 Susceptibility of HRS/J Mice to Listeriosis: Macrophage Activity. Wendy A. Archinal and Martin S. Wilder .......... .............................. 613-618 Characterization of the Susceptibility of Pseudomonas aeruginosa to ComplementMediated Killing: Role of Antibodies to the Rough Lipopolysaccharide on Serum-Sensitive Strains. Neal L. Schiller.............................. 632-639 Chemical Cross-Linking of Chlamydia trachomatis. Svend Birkelund, Anker G. Lundemose, and Gunna Christiansen .................................. 654-659 Serial Isolates of Pseudomonas aeruginosa from a Cystic Fibrosis Patient Have Identical Pilin Sequences. Brittan L. Pasloske, A. Mark Joffe, Qiming Sun, Kathy Volpel, William Paranchych, Fereshteh Eftekhar, and David P. Speert .............................................................. 665-672 Interaction of Macrophage Cationic Proteins with the Outer Membrane of Pseudomonas aeruginosa. Janet G. Sawyer, Nancy L. Martin, and R. E. W. Hancock............................................................ 693-698 Agglutinating Monoclonal Antibodies That Specifically Recognize Lipooligosaccharide A of Bordetella pertussis. Zhong Ming Li, James L. Cowell, Michael J. Brennan, Drusilla L. Bums, and Charles R. Manclark ..... .... 699-702 Serological Response to the Outer Membrane Lipoprotein in Animal Brucellosis. Mania J. G6mez-Miguel, Ignacio Moriy6n, B. Alonso-Urmeneta, J. I. Riezu-Boj, and R. Diaz............................................... 716-718","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43045114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-07DOI: 10.1201/9780824745097-11
Cell-mediated immunity is an integral part of our body’s immune system. This type of immunity is mediated by T-lymphocytes, also called T-cells. The functions of cell-mediated immunity are important and include defense against intracellular bacterial and viral infections. This is achieved by activating macrophages to destroy phagocytosed microbes via helper T-lymphocytes, or by directly killing infected cells via cytotoxic T-lymphocytes.
{"title":"Cell-Mediated Immunity","authors":"","doi":"10.1201/9780824745097-11","DOIUrl":"https://doi.org/10.1201/9780824745097-11","url":null,"abstract":"Cell-mediated immunity is an integral part of our body’s immune system. This type of immunity is mediated by T-lymphocytes, also called T-cells. The functions of cell-mediated immunity are important and include defense against intracellular bacterial and viral infections. This is achieved by activating macrophages to destroy phagocytosed microbes via helper T-lymphocytes, or by directly killing infected cells via cytotoxic T-lymphocytes.","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45782669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：